Acasti Pharma (GRCE) Free Cash Flow (2019 - 2026)
Acasti Pharma (GRCE) free cash flow from Jun 30, 2019 to Mar 31, 2026. The TTM Acasti Pharma (GRCE) free cash flow is -$8.86M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Acasti Pharma (GRCE) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -40.54% |
| 3 Years TTM | -17.74% |
| 5 Years TTM | -9.26% |
| All Time TTM | -13.80% |
Annual Free Cash Flow change of Acasti Pharma (GRCE)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$8.87M | -40.47% |
| 2025 | -$15M | +20.84% |
| 2024 | -$12M | -22.50% |
| 2023 | -$16M | -7.66% |
| 2022 | -$17M | +20.32% |
| 2021 | -$14M | -38.44% |
| 2020 | -$23M | -8.14% |
| 2019 | -$25M | +102.24% |
| 2018 | -$13M | +79.89% |
| 2017 | -$6.96M | +5.94% |
| 2016 | -$6.57M | N/A |
Comparison Acasti Pharma (GRCE) five years free cash flow CAGR with competitors
Acasti Pharma (GRCE) five years free cash flow CAGR is -9.14%.